The major components of XBJ, paeoniflorin and hydroxysafflor yellow A are identified can down-regulate GSDMD expression in depression and cerebral ischemia reperfusion models, respectively (Tan et al., 2020; Tian et al., 2021). Here, GSDMD is linked to depressive symptom measurement.